Literature DB >> 21681286

Tadalafil alters energy metabolism in C2C12 skeletal muscle cells.

Stefania Sabatini1, Paolo Sgrò, Guglielmo Duranti, Roberta Ceci, Luigi Di Luigi.   

Abstract

Phosphodiesterases (PDEs) are a family of enzymes that hydrolyze cyclic nucleotides, thereby modulating cell functions. Three highly selective PDE5 inhibitors (PDE5i), sildenafil, vardenafil and tadalafil, have been developed for treatment of erectile dysfunction (ED). Experimental evidence showed that chronic treatment with sildenafil PDE5i in a mouse model of diet-induced obesity and insulin resistance improved insulin action and decreased circulating fatty acid levels. It has recently been shown that healthy athletes use PDE5i as performance enhancers, hence in the present study we investigated whether the long-lasting PDE5i tadalafil influences energy metabolism in C2C12 skeletal muscle cells by evaluating lactate production, glucose consumption, and citrate synthase and 3-OH acyl CoA dehydrogenase activities. Our data demonstrate that tadalafil is able to modulate energy homeostasis in mouse skeletal muscle cells, depending on the treatment length and dose.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681286

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  23 in total

Review 1.  Andrological aspects of physical exercise and sport medicine.

Authors:  Luigi Di Luigi; Francesco Romanelli; Paolo Sgrò; Andrea Lenzi
Journal:  Endocrine       Date:  2012-03-20       Impact factor: 3.633

2.  Involvement of NO-cGMP pathway in anti-hyperalgesic effect of PDE5 inhibitor tadalafil in experimental hyperalgesia.

Authors:  K V Otari; C D Upasani
Journal:  Inflammopharmacology       Date:  2015-07-10       Impact factor: 4.473

3.  Short-term, supra-physiological rhGH administration induces transient DNA damage in peripheral lymphocytes of healthy women.

Authors:  C Fantini; P Sgrò; M Pittaluga; A de Perini; I Dimauro; A Sartorio; D Caporossi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-02-16       Impact factor: 4.256

4.  The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism.

Authors:  F Marampon; C Antinozzi; C Corinaldesi; G B Vannelli; E Sarchielli; S Migliaccio; L Di Luigi; A Lenzi; C Crescioli
Journal:  Endocrine       Date:  2017-08-07       Impact factor: 3.633

5.  Influence of the PDE5 inhibitor tadalafil on redox status and antioxidant defense system in C2C12 skeletal muscle cells.

Authors:  Guglielmo Duranti; Roberta Ceci; Paolo Sgrò; Stefania Sabatini; Luigi Di Luigi
Journal:  Cell Stress Chaperones       Date:  2017-03-11       Impact factor: 3.667

6.  Dihydrotestosterone (DHT) rapidly increase after maximal aerobic exercise in healthy males: the lowering effect of phosphodiesterase's type 5 inhibitors on DHT response to exercise-related stress.

Authors:  P Sgrò; C Minganti; M Lista; C Antinozzi; M Cappa; Y Pitsiladis; F Pigozzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2020-09-18       Impact factor: 4.256

Review 7.  Sport and male sexuality.

Authors:  P Sgrò; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-03-22       Impact factor: 4.256

8.  Effects of tadalafil administration on plasma markers of exercise-induced muscle damage, IL6 and antioxidant status capacity.

Authors:  Roberta Ceci; Guglielmo Duranti; Paolo Sgrò; Massimiliano Sansone; Laura Guidetti; Carlo Baldari; Stefania Sabatini; Luigi Di Luigi
Journal:  Eur J Appl Physiol       Date:  2014-11-09       Impact factor: 3.078

9.  Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization.

Authors:  Antonio Aversa; Simona Fittipaldi; Davide Francomano; Viviana M Bimonte; Emanuela A Greco; Clara Crescioli; Luigi Di Luigi; Andrea Lenzi; Silvia Migliaccio
Journal:  Endocrine       Date:  2017-01-30       Impact factor: 3.633

10.  Insulin-like effect of the phosphodiesterase type 5 inhibitor tadalafil onto male human skeletal muscle cells.

Authors:  C Crescioli; N Sturli; M Sottili; P Bonini; A Lenzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2013-07-15       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.